Report for: Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial

Title	Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial
Published in	Trials, September 2020
DOI	10.1186/s13063-020-04751-y
Pubmed ID	32998747
Authors	Sanjoy Chatterjee, Santam Chakraborty

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
India	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	1	50%
Scientists	1	50%

Mendeley readers

The data shown below were compiled from readership statistics for 62 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	62	100%

Readers by professional status	Count	As %
Other	6	10%
Student > Master	5	8%
Researcher	4	6%
Student > Ph. D. Student	3	5%
Student > Bachelor	3	5%
Other	10	16%
Unknown	31	50%

Readers by discipline	Count	As %
Medicine and Dentistry	11	18%
Nursing and Health Professions	4	6%
Unspecified	2	3%
Business, Management and Accounting	2	3%
Agricultural and Biological Sciences	2	3%
Other	7	11%
Unknown	34	55%

Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Ad…